SCHEMBL20892854

SCHEMBL20892854

CC(C)C1CCCC12CN(C(C)C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20892923 0.94 HRH3 (0.30) —
SCHEMBL19727312 0.81 — —
SCHEMBL19727296 0.81 — —
SCHEMBL19727289 0.81 — —
SCHEMBL19763794 0.81 — —
SCHEMBL19727291 0.79 HRH3 (0.31) —
SCHEMBL19727288 0.79 HRH3 (0.31) —
SCHEMBL19727290 0.79 HRH3 (0.31) —
SCHEMBL24244468 0.77 — —
SCHEMBL19727297 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10870652-B2 Compounds and methods for modulating bruton's tyrosine kinase CORVUS PHARMACEUTICALS, INC. (US) 2020-12-22 — — US disclosed
US-20190106423-A1 COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASE CORVUS BIOPHARMACEUTICALS, LTD. (KY) 2019-04-11 — — US disclosed
Send feedback